Berlin I, Marcel P, Uzzan B, Millon D, Le Hoang P, Puech A J
Clin Pharmacol Ther. 1987 Jun;41(6):622-6. doi: 10.1038/clpt.1987.85.
The systemic effect of three beta-blocking eyedrops was compared in a placebo-controlled, double-blind trial in 12 healthy male volunteers. Each subject received successively each treatment in random order at weekly intervals. The eyedrops administered were as follows: 0.5% timolol, 2% carteolol, 0.6% metipranolol, and placebo. We evaluated the intraocular pressure and systemic beta-blockade 3 hours after a single administration of one eyedrop in each eye. The systemic beta-blocking effect was evaluated by the isoproterenol sensitivity test, that is the dose of isoproterenol required to increase resting heart rate by 25 bpm (I25). Each beta-blocking eyedrop antagonized the chronotropic effect of isoproterenol. I25 for placebo was 3.1 +/- 0.5 micrograms, for metipranolol 5.2 +/- 0.9 micrograms (P less than 0.005), for timolol 10.9 +/- 1.9 micrograms (P less than 0.001), and for carteolol 39.6 +/- 5.4 micrograms (P less than 0.0005). Each treatment significantly decreased the intraocular pressure: metipranolol 3.6 +/- 0.4 mm Hg (P less than 0.001), timolol 2.44 +/- 0.4 mm Hg (P less than 0.01), and carteolol 2.38 +/- 0.48 mm Hg (P less than 0.01) compared with placebo. The resting heart rate and blood pressure were not influenced by the treatments. Even though the results might be different in the case of an earlier or a later time of evaluation or chronic administration, we believe that the isoproterenol sensitivity test may be used to evaluate the systemic effect of beta-blocking eyedrops.
在一项针对12名健康男性志愿者的安慰剂对照双盲试验中,比较了三种β受体阻滞剂眼药水的全身效应。每个受试者每周按随机顺序依次接受每种治疗。所使用的眼药水如下:0.5%噻吗洛尔、2%卡替洛尔、0.6%美替洛尔和安慰剂。在每只眼睛单次滴入一种眼药水3小时后,我们评估了眼压和全身β受体阻滞情况。通过异丙肾上腺素敏感性试验评估全身β受体阻滞效应,即使静息心率增加25次/分钟(I25)所需的异丙肾上腺素剂量。每种β受体阻滞剂眼药水都拮抗了异丙肾上腺素的变时效应。安慰剂的I25为3.1±0.5微克,美替洛尔为5.2±0.9微克(P<0.005),噻吗洛尔为10.9±1.9微克(P<0.001),卡替洛尔为39.6±5.4微克(P<0.0005)。每种治疗均显著降低了眼压:与安慰剂相比,美替洛尔降低了3.6±0.4毫米汞柱(P<0.001),噻吗洛尔降低了2.44±0.4毫米汞柱(P<0.01),卡替洛尔降低了2.38±0.48毫米汞柱(P<0.01)。静息心率和血压不受这些治疗的影响。尽管在更早或更晚的评估时间或长期给药的情况下结果可能不同,但我们认为异丙肾上腺素敏感性试验可用于评估β受体阻滞剂眼药水的全身效应。